Weight Loss Clinic in Philadelphia PA

ZEPBOUND TIRZEPATIDE MOUNJARO WEGOVY SEMAGLUTIDE PHENTERMINE ADIPEX

MEDICAL WEIGHT LOSS DOCTORS PRESCRIPTION WEIGHT LOSS TREATMENTS

Medical Weight Loss Philadelphia

7439 Frankford Avenue

Philadelphia, PA 19136

Physician Supervised Treatments for Weight Loss

At our Philadelphia weight loss clinic, we offer prescription weight loss medications under medical supervision, as well as nutritional counseling, to help you on your weight loss journey.


 Medications For Weight Loss Treatments

 Is a weight loss pill that suppresses appetite and makes the stomach feel fuller. phentermine makes it easier to stick to a diet plan to help you lose weight. It has been prescribed by doctors since 1959 and is one of the most widely prescribed weight loss drugs in the world. When combined with walking and a good diet, it has been shown to be effective for weight loss.

Vitamin B12 is a nutrient that helps keep your body’s blood and nerve cells healthy and helps make DNA, the genetic material in all of your cells. Vitamin B12 also helps prevent megaloblastic anemia, a blood condition that makes people tired and weak.

Zepbound (tirzepatide) is a prescription medication that helps adults with obesity or overweight and at least 1 weight-related condition manage their weight. It is the first FDA-approved treatment for obesity that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. 

These hormones naturally regulate blood sugar and appetite, and by activating them, Zepbound aids in weight loss and improves blood sugar control. Zepbound is administered through injections once a week, with the dosage gradually increased over time to minimize side effects. The dosage gradually increases over time to reach the target dosage of 5 mg, 10 mg, or 15 mg.

Clinical trials have demonstrated Zepbound's effectiveness in promoting weight loss, with participants losing an average of 19% of their body weight after 72 weeks of treatment, significantly more than those who received a placebo. 

The medication has also been proven to be safe and well-tolerated, with side effects such as nausea, vomiting, diarrhea, and constipation reported. However, Zepbound is not suitable for individuals with a history of pancreatitis, medullary thyroid cancer, or multiple endocrine neoplasia type 2, as well as pregnant or breastfeeding women. If you are considering Zepbound, consult your doctor to determine if it is the right option for you.

How does semaglutide work?

The FDA approves semaglutide for weight loss in a high-dose version, under the trade name Wegovy. Semaglutide is a glucagon-like peptide-1 (GLP-1) analog with indication in type 2 diabetes mellitus along with diet and exercise. In 2017, it received its first approval for injectable use in type 2 diabetes and in 2020, the approval was expanded to reduce cardiovascular risk in adults with type 2 diabetes and known cardiovascular disease.

FDA approves semaglutide for obesity

FDA approves semaglutide for chronically overweight or obese with at least one weight-related condition: type 2 diabetes, high blood pressure, or high cholesterol. In addition, the recommendation of a low-calorie diet and regular physical exercise is maintained.


It is a 2.4 mg injectable. for subcutaneous administration once a week. The dose should be gradually increased over 16 to 20 weeks to avoid adverse gastrointestinal effects. It will be indicated for adults with a body mass index (BMI) of 30 kg / m2 or more. For those with some of the aforementioned weight-related diseases, a BMI of 27 kg/m2 or higher would be considered.

Efficacy of Semaglutide

To assess the efficacy of semaglutide, three randomized clinical trials were conducted with 2,600 patients who received the drug.

One of the studies included adults without diabetes, with a mean age of 46 years and of whom 76% were women. The average BMI was 38 kg/m2 and the average weight was 105 kg. The average weight loss, compared to the placebo group, was 12.4% of the initial body weight.

In another study to evaluate efficacy in adults with type 2 diabetes, the mean age was 55 years and 51% were women. They had a baseline BMI of 36 kg/m2 and an average weight of 100 kg. With the application of the medication, a weight loss of 6.2% was achieved, compared to the placebo group.


Semaglutide Side Effects

The most common side effects were gastrointestinal: nausea, vomiting, diarrhea, aerogastria, flatulence, and abdominal pain. Hypoglycemia occurred among patients with type 2 diabetes. The technical data sheet warns of the potential risk of thyroid C cell tumors, so it should not be used in patients with a history of thyroid tumors.

Call 215-821-7336

Medical Weight Loss Philadelphia

7439 Frankford Avenue

Philadelphia, PA 19136

Welcome to Medical Weight Loss Philadelphia, where your health and wellness dreams become a reality. Our team, equipped with the latest in weight management science, is dedicated to guiding you towards a healthier, happier life.

Comprehensive Weight Loss Solutions

Why Choose Medical Weight Loss Philadelphia?

Engaging with Our Community

Begin Your Transformation Today

Medical Weight Loss Philadelphia is more than a clinic; it's a community dedicated to nurturing your wellness journey. Reach out to us and start rewriting your story today.

Virtual Reality/Augmented Reality Experiences

Innovative VR/AR Tools: Experience our cutting-edge VR/AR tools for simulating fitness goals and exercises, offering an immersive approach to your weight loss journey.